The Focus Diagnostics Simplexa™ Influenza B PCR Quantitative External Quality Control plays a crucial role in ensuring the precision and reproducibility of real-time reverse transcription polymerase chain reaction (RT-qPCR) assays used for the detection of Influenza B viral RNA. As diagnostic laboratories scale up their testing capacities during influenza season, quality control materials are indispensable for compliance and reliability.
Influenza B and Molecular Diagnostics
Influenza B viruses co-circulate with Influenza A, contributing significantly to global seasonal influenza epidemics. Unlike Influenza A, which is classified into multiple subtypes, Influenza B is divided into two main lineages: B/Yamagata and B/Victoria. These viruses are responsible for hospitalizations, particularly in children and the elderly, as reported by the CDC cdc.gov/flu.
Timely identification through molecular diagnostic tools is essential to reduce complications and initiate antiviral therapy. RT-qPCR, the gold standard for viral RNA detection, is highly sensitive and specific, but subject to variations caused by reagent instability, operator error, or instrument malfunction. Hence, external quality control (EQC) becomes a cornerstone of assay verification.
Role of Focus Simplexa™ External Quality Control
The Focus Simplexa™ EQC is formulated with non-infectious synthetic RNA constructs that mirror native Influenza B genomic targets. These RNA molecules are quantified using digital PCR methods, ensuring traceability to international standards. It is an off-the-shelf solution that simulates clinical samples, thereby serving as a benchmark for extraction-free or direct detection workflows.
Recommended for use with the Simplexa™ Flu A/B & RSV Direct Assay, this control aligns with CDC and FDA EUA-approved diagnostics (fda.gov). It also supports assay validation and proficiency testing, as advocated by the Association of Public Health Laboratories (aphl.org) and Clinical Laboratory Improvement Amendments (CLIA) (cms.gov).
Key Technical Features
- Synthetic RNA targets from both B/Yamagata and B/Victoria lineages
- Lyophilized format for long-term stability
- Lot-to-lot consistency validated against digital PCR standards
- Low limit of detection (LOD) and high linearity (R² > 0.99)
- Compatible with closed systems like Luminex ARIES and open RT-qPCR systems
![AffiCHECK® Focus Simplexa™ Influenza B PCR Quantitative External Quality Control [Mid Level]](https://affigen.com/cdn/shop/products/AffiCHECK_fb7b798a-3c7f-47a2-80e0-e24fad165dff_535x.png?v=1686502688)
Laboratory Integration and Data Interpretation
Laboratories at nih.gov, hopkinsmedicine.org, and cdc.gov/labtraining emphasize the importance of third-party EQC materials in daily operations. The threshold cycle (Ct) values obtained using the Focus Simplexa™ control must fall within an established reference range. Any deviation signals potential problems with the assay’s reagents, instruments, or personnel technique.
State laboratories such as those at mass.gov, health.ny.gov, and university labs at ucsf.edu and wustl.edu frequently implement these controls for internal verification and external audit compliance.
Regulatory and Quality Framework
The control supports regulatory criteria set by:
- FDA Center for Devices and Radiological Health (CDRH): fda.gov/medical-devices
- NIH Office of Laboratory Animal Welfare: olaw.nih.gov
- CDC Division of Laboratory Systems: cdc.gov/labsystems
- CAP Laboratory Accreditation Program: cap.org
Additionally, it supports grant compliance and reporting in conjunction with grants.nih.gov and federal health data repositories like healthdata.gov.
Professional Training and Continuing Education
Resources for ongoing laboratory training include:
- train.org
- medlineplus.gov/lab-tests
- researchtraining.nih.gov
- cdc.gov/flu/professionals
- ninds.nih.gov
Laboratory personnel are encouraged to routinely review their standard operating procedures (SOPs) and integrate EQC materials to stay aligned with best practices in molecular diagnostics.
Conclusion
The Focus Simplexa™ Influenza B PCR Quantitative External Quality Control is a high-performance standard designed to verify RT-qPCR assay reliability and accuracy. Its compatibility with diverse platforms, along with alignment to FDA, CDC, and CLIA guidelines, makes it an essential tool in public health laboratories, academic research facilities, and clinical diagnostics. In an era of rapidly evolving pathogens and high-throughput screening, maintaining assay consistency through trusted quality controls is indispensable for patient safety, data reproducibility, and regulatory compliance.